193 related articles for article (PubMed ID: 7672771)
21. Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course.
Sagnelli E; Coppola N; Marrocco C; Onofrio M; Sagnelli C; Coviello G; Scolastico C; Filippini P
J Clin Virol; 2006 Mar; 35(3):317-20. PubMed ID: 16316779
[TBL] [Abstract][Full Text] [Related]
22. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
[TBL] [Abstract][Full Text] [Related]
23. [Interferon-alpha in the treatment of chronic viral hepatitis].
Melman ML
Rev Gastroenterol Mex; 1994; 59(2 Suppl):46-8. PubMed ID: 8091094
[No Abstract] [Full Text] [Related]
24. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
[TBL] [Abstract][Full Text] [Related]
25. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
[TBL] [Abstract][Full Text] [Related]
26. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
Marinos G; Naoumov NV; Williams R
Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
Zielińska W; Korczak-Rogoń A; Paszkiewicz J; Kowalik M; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):359-66. PubMed ID: 9017152
[TBL] [Abstract][Full Text] [Related]
28. [Hepatitis B and C: current therapy].
Bruch HR; Höhner U; Müller R
Praxis (Bern 1994); 1998 Oct; 87(42):1408-12. PubMed ID: 9824948
[TBL] [Abstract][Full Text] [Related]
29. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
[TBL] [Abstract][Full Text] [Related]
30. [Alpha-interferon in the treatment of chronic hepatitis C in children].
Cinquetti M; Marchi D
Pediatr Med Chir; 1995; 17(6):501-7. PubMed ID: 8668583
[TBL] [Abstract][Full Text] [Related]
31. Triple hepatitis: frequency and treatment outcome of co/super-infection of hepatitis C and D among patients of hepatitis B.
Zuberi BF; Afsar S; Quraishy MS
J Coll Physicians Surg Pak; 2008 Jul; 18(7):404-7. PubMed ID: 18760062
[TBL] [Abstract][Full Text] [Related]
32. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J
Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209
[TBL] [Abstract][Full Text] [Related]
33. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
[TBL] [Abstract][Full Text] [Related]
35. Patterns of hepatitis C viremia in patients receiving hemodialysis.
Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
[TBL] [Abstract][Full Text] [Related]
36. Chronic hepatitis B: problem patients (including patients with decompensated disease).
Perrillo RP
J Hepatol; 1995; 22(1 Suppl):45-8. PubMed ID: 7602076
[TBL] [Abstract][Full Text] [Related]
37. Interferon therapy for chronic viral hepatitis.
di Bisceglie AM
N Engl J Med; 1994 Jan; 330(2):137-8. PubMed ID: 8259170
[No Abstract] [Full Text] [Related]
38. Chronic hepatitis B. Hope for decreasing its impact.
Di Bisceglie AM
Postgrad Med; 1995 Jul; 98(1):99-102, 105-6. PubMed ID: 7603950
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection.
Liaw YF
J Gastroenterol; 2002; 37 Suppl 13():65-8. PubMed ID: 12109669
[TBL] [Abstract][Full Text] [Related]
40. [Therapy of acute and chronic viral hepatitis C (non-A, non-B) with interferon-alpha].
Alscher DM; Bode JC
Med Klin (Munich); 1992 Oct; 87(10):532-9. PubMed ID: 1461219
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
